South Africa's Aspen finalizes GSK deal for $263 million

JOHANNESBURG Mon Dec 3, 2012 1:19am EST

Related Topics

JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare (APNJ.J) said on Monday it has finalized the acquisition of medicines from GlaxoSmithKline (GSK.L) for 163.8 million pounds ($263 million).

The deal, announced in August, was initially pegged at 172 million pounds.

($1 = 0.6240 British pounds)

(Reporting by Olivia Kumwenda; editing by David Dolan)